Streptococcus pneumoniae non-susceptibility and outpatient antimicrobial prescribing rates at the Alaska Native Medical Center

被引:3
|
作者
Stevens, Ryan W. [1 ]
Wenger, Jay [2 ]
Bulkow, Lisa [2 ]
Bruce, Michael G. [2 ]
机构
[1] Alaska Native Med Ctr, Anchorage, AK USA
[2] Ctr Dis Control & Prevent CDC, Arctic Invest Program, Div Preparedness & Emerging Infect, Natl Ctr Emerging & Zoonot Dis, Anchorage, AK 99508 USA
关键词
Streptococcus pneumoniae; invasive pneumococcal disease; antibiotic resistance; antibiotic prescribing; susceptibility; Alaska Natives; Alaska; PNEUMOCOCCAL CONJUGATE VACCINE; SEROTYPE DISTRIBUTION; RESISTANCE PATTERNS; ANTIBIOTIC USE; UNITED-STATES; MACROLIDE; CHILDREN; TRENDS; ERYTHROMYCIN; DISEASE;
D O I
10.3402/ijch.v72i0.22297
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. American Indian/Alaska Native (AI/AN) people suffer substantially higher rates of invasive pneumococcal disease (IPD) than the general US population. We evaluated antimicrobial prescribing data and their association with non-susceptibility in Streptococcus pneumoniae causing IPD in AI/AN people between 1992 and 2009. Methods. Antimicrobial use data were gathered from the electronic patient management system and included all prescriptions dispensed to Alaska Native patients aged 5 years and older from outpatient pharmacies at the Alaska Native Medical Center (ANMC). Antimicrobial susceptibility data were gathered from pneumococcal isolates causing IPD among Anchorage Service Unit AI/AN residents aged 5 years and older. Data were restricted to serotypes not contained in the pneumococcal vaccine (PCV7). Results. Over the study period, overall antimicrobial prescribing increased 59% (285/1,000 persons/year in 1992 to 454/1,000 persons per year in 2009, p < 0.001). Trimethoprim/sulfamethoxazole prescribing increased (43/1,000 persons/year in 1992 to 108/1,000 persons/year in 2009, p < 0.001) and non-susceptibility to trimethoprim/sulfamethoxazole in AI/AN patients >= 5 years of age increased in non-PCV7 serotypes (0-12%, p < 0.05). Similarly, prescribing rates increased for macrolide antibiotics (46/1,000 persons/year in 1992 to 84/1,000 persons/year in 2009, p < 0.05). We observed no statistically significant change over time in erythromycin non-susceptibility among non-PCV7 serotypes in AI/AN patients aged 5 years or greater (0-7%, p = 0.087). Conclusion. Antimicrobial prescribing patterns of some antibiotics in the AI/AN population corresponded to increased antimicrobial resistance in clinical isolates. This study highlights the on-going threat of antimicrobial resistance, the critical importance of judicious prescribing of antibiotics and the potential utility of prescribing data for addressing this issue.
引用
收藏
页数:9
相关论文
共 15 条
  • [1] Global trends in non-susceptibility rates of Streptococcus pneumoniae isolates to ceftriaxone: Data from the antimicrobial testing leadership and surveillance (ATLAS) programme, 2016-21
    Wang, Jiun-Ling
    Lai, Chih-Cheng
    Ko, Wen-Chien
    Hsueh, Po-Ren
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 63 (02)
  • [2] Streptococcus pneumoniae vaccination strategies and its expected impact on penicillin non-susceptibility in children under the age of five: Let's recap!
    Sabbar, Hiba
    Mahraoui, Chafik
    Garcia, Magdalena Bastias
    Jroundi, Imane
    VACCINE: X, 2022, 11
  • [3] Evolution of Penicillin Non-susceptibility Among Streptococcus pneumoniae Isolates Recovered From Asymptomatic Carriage and Invasive Disease Over 25 years in Brazil, 1990-2014
    Abreu Pinto, Tatiana Castro
    Goncalves Neves, Felipe Piedade
    Vianna Souza, Aline Rosa
    Andrade Oliveira, Laura Maria
    Costa, Natalia Silva
    Souza Castro, Luciana Fundao
    de Vieira Mendonca-Souza, Claudia Rezende
    Peralta, Jose Mauro
    Teixeira, Locia Martins
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [4] Serotype/serogroup-specific antibiotic non-susceptibility of invasive and non-invasive Streptococcus pneumoniae, Switzerland, 2004 to 2014
    Hauser, C.
    Kronenberg, A.
    Allemann, A.
    Muehlemann, K.
    Hilty, M.
    EUROSURVEILLANCE, 2016, 21 (21): : 12 - 21
  • [5] Increase in serotype 19A prevalence and amoxicillin non-susceptibility among paediatric Streptococcus pneumoniae isolates from middle ear fluid in a passive laboratory-based surveillance in Spain, 1997-2009
    Fenoll, Asuncion
    Aguilar, Lorenzo
    Vicioso, Maria-Dolores
    Gimenez, Maria-Jose
    Robledo, Olga
    Granizo, Juan-Jose
    BMC INFECTIOUS DISEASES, 2011, 11
  • [6] Non-typeable Streptococcus pneumoniae infection in a medical center in Taiwan after wide use of pneumococcal conjugate vaccine
    Chen, Hsin-Hang
    Hsu, Mei-Hua
    Wu, Tsu-Lan
    Li, Hsin-Chieh
    Chen, Chyi-Liang
    Janapatla, Rajendra Prasad
    Su, Lin-Hui
    Chiu, Cheng-Hsun
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2020, 53 (01) : 94 - 98
  • [7] TRENDS IN ANTIMICROBIAL PRESCRIBING RATES FOR ALASKA NATIVE AND AMERICAN INDIAN PERSONS &lt; 18 YEARS OF AGE RESIDING IN THE ANCHORAGE REGION
    Bott, Anne M.
    Bruce, Michael G.
    Bulkow, Lisa
    Coleman, John
    Hennessy, Thomas W.
    INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH, 2009, 68 (04) : 337 - 346
  • [8] Clinical characteristics and antimicrobial susceptibility of non-vaccine serotype Streptococcus pneumoniae in adult Japanese patients with pneumonia
    Akata, Kentaro
    Yamasaki, Kei
    Noguchi, Shingo
    Chang, Bin
    Nemoto, Kazuki
    Ikegami, Hiroaki
    Kawanami, Toshinori
    Mukae, Hiroshi
    Yatera, Kazuhiro
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (04) : 286 - 291
  • [9] Antibiotic non-susceptibility among Streptococcus pneumoniae and Haemophilus influenzae isolates identified in African cohorts: a meta-analysis of three decades of published studies
    Ginsburg, Amy Sarah
    Tinkham, Laura
    Riley, Katherine
    Kay, Noa A.
    Klugman, Keith P.
    Gill, Christopher J.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 (06) : 482 - 491
  • [10] Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014
    Nakano, Satoshi
    Fujisawa, Takao
    Ito, Yutaka
    Chang, Bin
    Suga, Shigeru
    Noguchi, Taro
    Yamamoto, Masaki
    Matsumura, Yasufumi
    Nagao, Miki
    Takakura, Shunji
    Ohnishi, Makoto
    Ihara, Toshiaki
    Ichiyama, Satoshi
    VACCINE, 2016, 34 (01) : 67 - 76